Amneal Pharmaceuticals, Inc. Income Statement

Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1,018.23M1,033.65M1,662.99M1,626.37M1,992.52M2,093.67M2,212.30M2,393.61M2,793.96M
Cost of Revenue 420.77M507.48M938.77M1,147.21M1,329.55M1,324.70M1,427.60M1,573.04M1,773.52M
Gross Profit 597.46M526.18M716.40M353.00M628.39M768.97M784.71M820.57M1,020.44M
Operating items
Research & Development 179.02M171.42M194.19M188.05M179.93M201.85M195.69M163.95M190.71M
Selling, General & Administrative 118.76M109.05M227.85M289.60M326.73M365.50M399.70M429.68M476.44M
Restructuring Costs 0.07M9.40M56.41M34.34M9.00M8.10M1.42M1.75M2.35M
Other Operating Expenses 11.00M-340.22M19.71M-12.44M-5.86M-25.00M-269.93M14.50M-96.69M
Operating Expenses 297.85M289.87M478.45M511.99M515.66M575.45M596.81M595.37M669.50M
Operating Income 284.88M245.10M-19.67M-248.68M91.16M152.72M-94.93M204.37M249.33M
EBIT 284.88M245.10M-19.67M-248.68M91.16M152.72M-94.93M204.37M249.33M
Non-operating items
Interest & Investment Income -55.28M-71.06M-143.57M-168.21M-146.00M-136.32M-158.38M-210.63M-258.60M
Other Non Operating Income -14.11M29.09M-20.00M-4.96M16.35M15.33M18.46M-40.80M11.78M
Non Operating Income -70.06M-73.78M-183.05M28.44M-126.94M-121.35M-153.20M-244.64M-304.34M
Net income details
EBT 214.82M171.32M-202.72M-220.24M-35.78M31.37M-248.13M-40.27M-55.01M
Tax Provisions 5.39M2.00M-1.42M383.33M-104.40M11.20M6.70M8.50M18.90M
Profit After Tax 209.43M169.32M-201.30M-603.57M68.58M20.17M-254.79M-48.72M-73.88M
Income from Non-Controlling Interests 2.05M1.68M-32.75M-241.66M-22.48M9.55M-125.24M35.27M43.01M
Income from Continuing Operations 209.43M169.32M-201.30M-603.57M68.62M20.17M-254.83M-48.77M-73.91M
Consolidated Net Income 209.43M169.32M-201.30M-603.57M68.62M20.17M-254.83M-48.77M-73.91M
Income towards Parent Company 209.43M169.32M-201.30M-603.57M68.62M20.17M-254.83M-48.77M-73.91M
Preferred Dividend Payments 1.18M0.44M
Net Income towards Common Stockholders 209.43M169.32M-20.92M-361.92M91.06M10.62M-129.99M-83.99M-116.89M
Additional items
EPS (Basic) 0.700.57-0.16-2.740.620.07-0.86-0.48-0.38
EPS (Weighted Average and Diluted) -0.16-2.740.610.07-0.86-0.48-0.38
Shares Outstanding (Weighted Average) 298.47M298.47M298.57M299.10M299.75M301.49M303.59M306.54M309.84M
Shares Outstanding (Diluted Average) 127.25M132.11M148.91M150.94M176.14M308.98M
EBITDA 284.88M245.10M-19.67M-248.68M91.16M152.72M-94.93M204.37M249.33M
Tax Rate 2.51%1.17%0.70%35.71%